CRIS Curis Inc
13,977
$16.03
$0.3306
(2.02%)
| Watchers | 13,977 |
| 52-Wk Low | $3.80 |
| 52-Wk High | $19.60 |
| Market Cap | $96.43M |
| Volume | 4,168.00 |
| 52-Wk High | $19.60 |
| 52-Wk Low | $3.80 |
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024PR Newswire • 6 days ago
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 PR Newswire...
Share to Feed
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire LEXINGTON, Mass., April 5, 2024 LEXINGTON, Mass...
Curis to Present at Upcoming Healthcare Conferences in April Curis to Present at Upcoming Healthcare Conferences in April PR Newswire LEXINGTON, Mass., April 4, 2024 LEXINGTON, Mass., April 4, 2024...
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis...
Curis (NASDAQ:CRIS Get Free Report) and Ambrx Biopharma (NYSE:AMAM Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Curis Provides Fourth Quarter 2023 Business Update Curis Provides Fourth Quarter 2023 Business Update PR Newswire LEXINGTON, Mass., Feb. 8, 2024 Emavusertib data presented at ASH showed 3 of 5...
Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024 Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024...
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire LEXINGTON, Mass., Jan. 5, 2024 LEXINGTON, Mass...